Related Experiment Videos
Infrainguinal revascularization in the diabetic patient
1Vascular Surgery Unit, Royal Infirmary, Edinburgh, UK.
The British Journal of Surgery
|October 1, 1993
Summary
Diabetic patients may not have significant small-vessel disease limiting infrainguinal bypass grafting. Early, aggressive treatment of lower-limb occlusive disease is encouraged for better outcomes.
Area of Science:
- Vascular Surgery
- Diabetology
- Epidemiology
Background:
- Infrainguinal arterial reconstruction is a key intervention for lower-limb ischemia.
- Diabetic patients often present with complex vascular disease.
- The role of small-vessel disease in diabetic lower-limb complications requires clarification.
Purpose of the Study:
- To review the evidence regarding small-vessel disease in diabetic patients undergoing infrainguinal arterial reconstruction.
- To evaluate the outcomes of infrainguinal vascular reconstruction in diabetic populations.
- To inform treatment strategies for lower-limb occlusive disease in diabetes.
Main Methods:
- Literature review of epidemiological, anatomical, and physiological data.
- Analysis of published results of infrainguinal bypass grafting in diabetic patients.
Main Results:
- No definitive evidence supports surgically significant small-vessel disease as a primary cause of diabetic foot lesions or a limiter of bypass success.
- Published results of infrainguinal reconstruction in diabetic patients are encouraging.
- Early and aggressive intervention for lower-limb occlusive disease appears beneficial in diabetic patients.
Conclusions:
- Small-vessel disease may not be a contraindication for infrainguinal bypass grafting in diabetic patients.
- Infrainguinal vascular reconstruction can be successful in diabetic patients.
- Prompt and assertive management of lower-limb arterial disease is recommended for individuals with diabetes.